Cimzia 200 mg in 1 mL Prefilled Syringe
RxNorm 849599
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 849599 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Cimzia 200 mg in 1 mL Prefilled Syringe.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
1 mL certolizumab pegol 200 mg/ML Prefilled Syringe [Cimzia]
(Atom ID: 2969242)
SYPrescribable
Synonym (SY):
1ML Cimzia 200 mg/ML Prefilled Syringe
(Atom ID: 3608534)
PSNPrescribable
Prescribable Name (PSN):
Cimzia 200 mg in 1 mL Prefilled Syringe
(Atom ID: 8728060)
SYPrescribable
Synonym (SY):
Cimzia 200 mg per 1 mL Prefilled Syringe
(Atom ID: 3608535)
Patient Education
Certolizumab Injection
Certolizumab injection is used to relieve the symptoms of certain autoimmune disorders (conditions in which the immune system attacks healthy parts of the body and causes pain, swelling, and damage) including the following: Crohn's disease (a condition in which the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss, and fever) that has not improved when treated with other medications, rheumatoid arthritis (a condition in which the body attacks its own joints, causing pain, swelling, and loss of function), psoriatic arthritis (a condition that causes joint pain and swelling and scales on the skin), active ankylosing spondylitis (a condition in which the body attacks the joints of the spine and other areas causing pain, swelling, and joint damage) with changes seen on X-ray, active non-radiographic axial spondyloarthritis (a condition in which the body attacks the joints of the spine and other areas causing pain and signs of swelling), but without changes seen on X-ray, plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) in people who may benefit from medications or phototherapy (a treatment that involves exposing the skin to ultraviolet light). Certolizumab injection is in a class of medications called tumor necrosis factor (TNF) inhibitors. It works by blocking the activity of TNF, a substance in the body that causes inflammation.
[Learn More]
* Please review the disclaimer below.
